Technical Analysis for TLC - Taiwan Liposome Company, Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
5.15 | -4.59% | -0.25 |
TLC closed down 4.59 percent on Tuesday, February 18, 2020, on 1.11 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical TLC trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Crossed Above 200 DMA | Bullish | -4.59% | |
| Crossed Above 20 DMA | Bullish | -4.59% | |
| Crossed Above 50 DMA | Bullish | -4.59% | |
| Narrow Range Bar | Range Contraction | -4.59% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2019
- Sector: Healthcare
- Industry: Biotechnology
Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Biopharmaceutical Drugs Inflammation Pharmacology Drug Delivery Arthritis Macular Edema Peripheral Arterial Disease Amphotericin B Arbutus Biopharma Bupivacaine Doxorubicin Liposome
Biopharmaceutical Drugs Inflammation Pharmacology Drug Delivery Arthritis Macular Edema Peripheral Arterial Disease Amphotericin B Arbutus Biopharma Bupivacaine Doxorubicin Liposome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.0 |
| 52 Week Low | 4.61 |
| Average Volume | 3,860 |
| 200-Day Moving Average | 5.36 |
| 50-Day Moving Average | 5.32 |
| 20-Day Moving Average | 5.34 |
| 10-Day Moving Average | 5.23 |
| Average True Range | 0.30 |
| ADX | 36.63 |
| +DI | 45.53 |
| -DI | 17.45 |
| Chandelier Exit (Long, 3 ATRs ) | 4.94 |
| Chandelier Exit (Short, 3 ATRs ) | 5.74 |
| Upper Bollinger Band | 5.75 |
| Lower Bollinger Band | 4.94 |
| Percent B (%b) | 0.26 |
| BandWidth | 15.12 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.02 |
| MACD Histogram | -0.0124 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.80 | ||||
| Resistance 3 (R3) | 5.87 | 5.72 | 5.69 | ||
| Resistance 2 (R2) | 5.72 | 5.56 | 5.69 | 5.65 | |
| Resistance 1 (R1) | 5.44 | 5.46 | 5.37 | 5.37 | 5.62 |
| Pivot Point | 5.29 | 5.29 | 5.26 | 5.26 | 5.29 |
| Support 1 (S1) | 5.01 | 5.13 | 4.94 | 4.94 | 4.68 |
| Support 2 (S2) | 4.86 | 5.03 | 4.83 | 4.65 | |
| Support 3 (S3) | 4.58 | 4.86 | 4.61 | ||
| Support 4 (S4) | 4.51 |
